The booming world of alternative proteins presents exciting opportunities, but regulatory hurdles can trip up even the most innovative players. Join us for a strategic deep-dive into the 'regulatory conversation': a practical and insightful discussion designed to empower your success. As alternative protein companies proliferate globally despite investment headwinds, political turmoil and war, the evolving regulatory conversation remains more important than ever. Approvals from regulators in USA and Singapore in particular, continue to be among the most coveted. During this panel discussion, we will translate key US regulatory considerations into practical insights for cultivated meat, molecular farming and precision fermentation companies to apply as they scale operations. We will address a number of important questions such as, How early is too early to engage with regulators? What are the right questions to ask? What advisors are needed to facilitate the most efficient and fruitful engagement with regulators? We’ll consider this and more, with a focus on engagement with US food-tech regulators, the FDA and USDA.

‍

‍